CN116059138A - Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics - Google Patents
Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics Download PDFInfo
- Publication number
- CN116059138A CN116059138A CN202211367265.6A CN202211367265A CN116059138A CN 116059138 A CN116059138 A CN 116059138A CN 202211367265 A CN202211367265 A CN 202211367265A CN 116059138 A CN116059138 A CN 116059138A
- Authority
- CN
- China
- Prior art keywords
- chlorella
- water
- skin care
- water extract
- jinxiao
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195649 Chlorella <Chlorellales> Species 0.000 title claims abstract description 93
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 19
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 26
- 230000001815 facial effect Effects 0.000 claims abstract description 23
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 22
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000220317 Rosa Species 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- 229960000271 arbutin Drugs 0.000 claims abstract description 11
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 244000005700 microbiome Species 0.000 claims abstract 2
- 241000195493 Cryptophyta Species 0.000 claims description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 19
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000195654 Chlorella sorokiniana Species 0.000 claims description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 9
- 229960001631 carbomer Drugs 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 9
- 229940069338 potassium sorbate Drugs 0.000 claims description 9
- 239000004302 potassium sorbate Substances 0.000 claims description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 235000010413 sodium alginate Nutrition 0.000 claims description 9
- 239000000661 sodium alginate Substances 0.000 claims description 9
- 229940005550 sodium alginate Drugs 0.000 claims description 9
- 229940032094 squalane Drugs 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000008269 hand cream Substances 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 229960004418 trolamine Drugs 0.000 claims description 2
- 239000006286 aqueous extract Substances 0.000 claims 4
- 230000001804 emulsifying effect Effects 0.000 claims 2
- 238000009924 canning Methods 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 11
- 239000003963 antioxidant agent Substances 0.000 abstract description 10
- 235000006708 antioxidants Nutrition 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 6
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 239000003102 growth factor Substances 0.000 abstract description 5
- 229960003966 nicotinamide Drugs 0.000 abstract description 5
- 235000005152 nicotinamide Nutrition 0.000 abstract description 5
- 239000011570 nicotinamide Substances 0.000 abstract description 5
- 238000004321 preservation Methods 0.000 abstract description 5
- 239000013543 active substance Substances 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 230000005855 radiation Effects 0.000 abstract description 4
- 238000010790 dilution Methods 0.000 abstract description 3
- 239000012895 dilution Substances 0.000 abstract description 3
- 230000002000 scavenging effect Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000012163 sequencing technique Methods 0.000 description 8
- 101150087323 COI gene Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 5
- 108020004463 18S ribosomal RNA Proteins 0.000 description 4
- 230000002438 mitochondrial effect Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 101000919849 Homo sapiens Cytochrome c oxidase subunit 1 Proteins 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000002856 computational phylogenetic analysis Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 101100366043 Caenorhabditis elegans sms-2 gene Proteins 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007434 physicochemical evaluation Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了具有抗氧化活性的索罗金小球藻及其在化妆品中的应用。本发明分离鉴定到一株索罗金小球藻藻株,其微生物保藏编号是:CCTCC M 20221450。本发明所提供的索罗金小球藻水提液富含多糖、生长因子等活性成分,对DPPH有较好的清除作用,体外抗氧化能力突出。采用索罗金小球藻水提液制备的面膜精华液经100倍稀释后,DPPH清除率超过90%,抗氧化能力强,护肤效果佳。不仅含有小球藻的活性物质,还含有维生素C、烟酰胺、熊果苷、玫瑰纯露等抗氧化、美白的植物天然活性护肤成分,多种成分复配,协同作用,使用后皮肤水润细腻,有弹性,护肤效果佳,不仅抗氧化能力突出,还具有防辐射、修复肌肤等功效。
The invention discloses chlorella sorokinus with antioxidant activity and its application in cosmetics. The present invention isolates and identifies a strain of Chlorella sorokini, and its microorganism preservation number is: CCTCC M 20221450. The water extract of chlorella sorokinus provided by the invention is rich in active ingredients such as polysaccharides and growth factors, has a good scavenging effect on DPPH, and has outstanding antioxidation ability in vitro. After 100-fold dilution of the facial mask essence prepared with Sorokin chlorella water extract, the DPPH clearance rate exceeds 90%, with strong antioxidant capacity and good skin care effect. Not only does it contain the active substances of chlorella, but it also contains antioxidant and whitening plant natural active skin care ingredients such as vitamin C, niacinamide, arbutin, and rose hydrosol. The compounding of various ingredients works synergistically, and the skin is moisturized after use Delicate, elastic, good skin care effect, not only has outstanding anti-oxidation ability, but also has effects of radiation protection and skin repair.
Description
技术领域technical field
本发明涉及小球藻(Chlorella),尤其涉及具有抗氧化活性的索罗金小球藻(Chlorella sorokiniana)及其在化妆品中的应用,属于小球藻及其应用领域。The invention relates to chlorella (Chlorella), in particular to chlorella sorokiniana (Chlorella sorokiniana) with antioxidant activity and its application in cosmetics, belonging to the field of chlorella and its application.
背景技术Background technique
小球藻(Chlorella)是一种古老的单细胞真核绿藻,起源于约5亿多年前,经历了地球5次生物大灭绝而幸存,具有广泛的适应性和良好的抗逆性,具有极大的开发价值。Chlorella is an ancient single-celled eukaryotic green algae, which originated about 500 million years ago and survived five mass extinctions on the earth. It has wide adaptability and good stress resistance. It has great development value.
小球藻富含生长因子(CGF)、多糖等活性成分,具有滋养皮肤、补水保湿等作用,可应用于化妆品。特别的是,小球藻独特的CGF生长因子又被称为“绿藻精”,是一种水溶性的混合物,包括蛋白质、氨基酸、核苷酸、多糖、维生素等,含量分别达到56.6%、42.59%、6.8%、4.8%、1.7%等,具有极强的抗氧化活性,可被应用到护肤品中,起到促进生长、抗衰老、修复组织、活化细胞等作用,通过热水提取,可获得包括生长因子在内的活性物质;但是现有的小球藻抗氧化能力不够显著,应用于化妆品上的护肤效果不佳,有待改进。Chlorella is rich in active ingredients such as growth factor (CGF) and polysaccharides. It has the functions of nourishing the skin, replenishing water and moisturizing, and can be applied to cosmetics. In particular, the unique CGF growth factor of chlorella, also known as "chlorella essence", is a water-soluble mixture, including proteins, amino acids, nucleotides, polysaccharides, vitamins, etc., with contents of 56.6%, 42.59%, 6.8%, 4.8%, 1.7%, etc., have strong antioxidant activity and can be applied to skin care products to promote growth, anti-aging, repair tissue, activate cells, etc., through hot water extraction, Active substances including growth factors can be obtained; however, the existing chlorella's antioxidant capacity is not significant enough, and the skin care effect applied to cosmetics is not good, and needs to be improved.
因此筛选出具有更高抗氧化活性的小球藻藻株,将其应用于制备护肤效果显著的化妆品,将具有重要的应用价值。Therefore, screening out chlorella algae strains with higher antioxidant activity and applying them to the preparation of cosmetics with significant skin care effects will have important application value.
发明内容Contents of the invention
本发明的目的之一是提供一株具有高抗氧化活性的索罗金小球藻(Chlorellasorokiniana)藻株;One of the objects of the present invention is to provide a Chlorella sorokiniana (Chlorellasorokiniana) strain with high antioxidant activity;
本发明的目的之二是将所述的索罗金小球藻应用于制备美容护肤制品;The second object of the present invention is to apply the described Chlorella sorogenus to the preparation of cosmetic and skin care products;
本发明的上述目的是通过以下技术方案来实现的:Above-mentioned purpose of the present invention is achieved through the following technical solutions:
本发明从四川巴中市南江县一稻田土样中分离鉴定到一株新的索罗金小球藻藻株(Chlorella sorokiniana)BZ942,其微生物保藏编号是:CCTCC NO:M 20221450,其分类命名是:Chlorella sorokiniana BZ942,保存于中国典型培养物保藏中心,保藏地址是:中国武汉武汉大学,保藏时间是:2022年9月20日。The present invention isolates and identifies a new Chlorella sorokiniana strain (Chlorella sorokiniana) BZ942 from a paddy field soil sample in Nanjiang County, Bazhong City, Sichuan Province. Its microbial preservation number is: CCTCC NO: M 20221450, and its classification name is: Chlorella sorokiniana BZ942, preserved in the China Center for Type Culture Collection, the preservation address is: Wuhan University, Wuhan, China, and the preservation time is: September 20, 2022.
本发明所分离的索罗金小球藻藻株BZ942藻株在显微镜下呈绿色、球状单细胞,有1个蛋白核,细胞直径大小约5微米。The chlorella sorokinus strain BZ942 strain isolated by the present invention is green and spherical single cell under a microscope, has a protein nucleus, and the cell diameter is about 5 microns.
所述的索罗金小球藻藻株BZ942的ITS基因的核苷酸序列为SEQ ID No.1),测序后经过Blastn比对,发现BZ942与索罗金小球藻ITS基因亲缘关系相近,一致性达到90.4%;所述的索罗金小球藻藻株BZ942的18s rRNA基因的核苷酸序列为SEQ ID No.2所示,经过Blastn比对,发现BZ942与索罗金小球藻核糖体RNA基因亲缘关系相近,一致性达到97.9%;所述的索罗金小球藻藻株BZ942的COI基因(线粒体细胞色素C氧化酶I基因)的核苷酸序列为SEQ ID No.3所示,经过Blastn比对,发现BZ942与索罗金小球藻线粒体COI基因亲缘关系相近,一致性达到98.67%,基于COI基因,进行进化树图分析,发现BZ942聚于索罗金小球藻分支。The nucleotide sequence of the ITS gene of the Chlorella sorokinensis strain BZ942 is SEQ ID No.1), after sequencing, through Blastn comparison, it is found that BZ942 is similar to the ITS gene of Chlorella sorokinii, and the consistency reaches 90.4 %; the nucleotide sequence of the 18s rRNA gene of the Chlorella sorokines algal strain BZ942 is shown in SEQ ID No.2, after Blastn comparison, it is found that BZ942 is close to the ribosomal RNA gene of Chlorella sorokines, Consistency reaches 97.9%; The nucleotide sequence of the COI gene (mitochondrial cytochrome C oxidase I gene) of the described Chlorella sorokini algal strain BZ942 is shown in SEQ ID No.3, after Blastn comparison, it is found that BZ942 The phylogenetic relationship with the mitochondrial COI gene of Chlorella sorokinensis is similar, with a consistency of 98.67%. Based on the COI gene, the phylogenetic tree analysis shows that BZ942 is aggregated in the Chlorella sorokinensis branch.
本发明提供了一种索罗金小球藻BZ942的水提液,其制备方法包括:(1)将索罗金小球藻BZ942通过培养基无菌发酵培养获得藻液;(2)将藻液离心,取沉淀干燥获得藻粉;(3)将水与藻粉混合得到混合液;(4)将混合液用超声处理后再采用80-100℃高温孵育;(5)离心,收集上清液,过滤,获得索罗金小球藻水提液。The invention provides a water extract of Chlorella sorokini BZ942, the preparation method of which comprises: (1) aseptically fermenting and culturing the Chlorella sorokini BZ942 to obtain the algae liquid; (2) centrifuging the algae liquid, and taking Precipitate and dry to obtain algae powder; (3) mix water and algae powder to obtain a mixed solution; (4) treat the mixed solution with ultrasound and then incubate at a high temperature of 80-100°C; (5) centrifuge, collect the supernatant, filter, Obtain the Sorokin chlorella water extract.
优选的,步骤(1)中将索罗金小球藻BZ942通过BG11培养基无菌发酵1-6天培养获得藻液;优选的,步骤(2)中所述的离心是离心转速是13000rpm/min,离心时间是10min;优选的,步骤(3)中将水与藻粉按照40mL:1g的比例进行混合;优选的,步骤(4)中是采用50%功率的超声破碎10min再经95℃高温孵育30min;优选的,步骤(5)中所述的离心是10000rpm/min离心10min;所述的过滤采用0.22μm滤膜过滤。Preferably, in step (1), Chlorella sorokini BZ942 is cultured to obtain the algae liquid through aseptic fermentation of BG11 medium for 1-6 days; preferably, the centrifugal speed described in step (2) is 13000rpm/min, The centrifugation time is 10min; preferably, in step (3), water and algae powder are mixed according to the ratio of 40mL: 1g; preferably, in step (4), ultrasonic crushing with 50% power is used for 10min and then incubated at 95°C 30min; preferably, the centrifugation described in step (5) is 10000rpm/min centrifugation for 10min; the described filtration adopts 0.22μm membrane filtration.
本发明所提供的索罗金小球藻BZ942水提液富含多糖、生长因子等活性成分,对DPPH有较好的清除作用,5mg/mL的小球藻水提液DPPH清除率达到70%,体外抗氧化能力突出,应用其制备的小球藻面膜精华液品质优异,抗氧化能力强,护肤效果佳。The water extract of Chlorella sorokinensis BZ942 provided by the present invention is rich in active ingredients such as polysaccharides and growth factors, and has a good scavenging effect on DPPH, and the DPPH clearance rate of the chlorella water extract of 5 mg/mL reaches 70%. The anti-oxidation ability is outstanding, and the chlorella mask essence prepared by using it has excellent quality, strong anti-oxidation ability, and good skin care effect.
本发明进一步提供了一种含有索罗金小球藻BZ942水提液的面膜精华液,由索罗金小球藻水提液、角鲨烷、维生素C、烟酰胺、熊果苷、玫瑰纯露、甘油、丙二醇、黄原胶、海藻酸钠、卡波姆、三乙醇胺、山梨酸钾和水组成;优选的,各组分的百分比为:索罗金小球藻水提液5%~10%、角鲨烷1%~6%、维生素C 0.2%~0.6%、烟酰胺0.1%~0.5%、熊果苷0.3%~0.9%、玫瑰纯露2%~10%、甘油2%~6%、丙二醇2%~6%、黄原胶0.01%~0.08%、海藻酸钠0.1%~0.5%、卡波姆0.1%~0.5%、三乙醇胺0.01%~0.05%、山梨酸钾0.2%~0.8%、水70%~80%;优选地,各组分的百分比为:索罗金小球藻水提液3%、角鲨烷3%、维生素C 0.2%、烟酰胺0.5%、熊果苷0.5%、玫瑰纯露5%、甘油5%、丙二醇2%、黄原胶0.05%、海藻酸钠0.3%、卡波姆0.2%、三乙醇胺0.05%、山梨酸钾0.5%、水79.7%。The present invention further provides a facial mask essence containing Chlorella sorogenus BZ942 water extract, which consists of Chlorella sorogenus water extract, squalane, vitamin C, nicotinamide, arbutin, rose hydrosol, glycerin, Propylene glycol, xanthan gum, sodium alginate, carbomer, triethanolamine, potassium sorbate and water; preferably, the percentages of each component are: 5% to 10% of Sorokin chlorella water extract,
本发明进一步提供了一种制备所述含有索罗金小球藻BZ942水提液的面膜精华液的方法,包括:(1)将黄原胶、卡波姆、海藻酸钠和水混合85℃~90℃加热并搅拌均匀至无白色固体;(2)加入甘油、丙二醇和三乙醇胺搅拌均匀,停止加热,冷却至45℃以下;3)加入索罗金小球藻水提液、山梨酸钾、角鲨烷、维生素C、烟酰胺、熊果苷和玫瑰纯露搅拌均匀,经乳化机乳化,获得面膜液初制品,静置2-3d;4)将面膜液初制品经辐射灭菌后,罐装,形成小球藻面膜精华液成品,配合面膜纸即可使用。The present invention further provides a method for preparing the mask essence containing Chlorella sorokinensis BZ942 water extract, comprising: (1) mixing xanthan gum, carbomer, sodium alginate and water at 85° C. to 90° C. Heat at ℃ and stir until there is no white solid; (2) Add glycerin, propylene glycol and triethanolamine and stir evenly, stop heating, and cool to below 45°C; 3) Add Sorokin chlorella water extract, potassium sorbate, squalane , vitamin C, niacinamide, arbutin and rose hydrosol are stirred evenly, emulsified by an emulsifier to obtain the primary product of the facial mask liquid, and left to stand for 2-3 days; 4) After the primary product of the facial mask liquid is sterilized by radiation, it can be packed in Form the finished product of chlorella mask essence, which can be used with mask paper.
本发明提供的索罗金小球藻BZ942面膜精华液经100倍稀释后,DPPH清除率超过90%,抗氧化能力强,护肤效果佳。其黏度适度,为半透明胶质,含有淡淡的玫瑰清香,温和不刺激,抗氧化效果效果显著,不仅含有小球藻BZ942的活性物质,还含有维生素C、烟酰胺、熊果苷、玫瑰纯露等抗氧化、美白的植物天然活性护肤成分,多种成分复配,协同作用,使用后皮肤水润细腻,有弹性,护肤效果佳,不仅抗氧化能力突出,还具有防辐射、修复肌肤等功效,可应用于防晒霜、护手霜、爽肤水、身体乳等多种化妆品。The chlorella sorogenus BZ942 facial mask essence provided by the invention has a DPPH clearance rate of more than 90% after being diluted 100 times, has strong antioxidant capacity and good skin care effect. Its viscosity is moderate, it is translucent colloid, contains a touch of rose fragrance, mild and non-irritating, and has a significant antioxidant effect. It not only contains the active substance of chlorella BZ942, but also contains vitamin C, niacinamide, arbutin, rose pure Antioxidant and whitening plant natural active skin care ingredients such as dew, compounded with various ingredients, synergistically, after use, the skin is moist and delicate, elastic, and the skin care effect is good. It not only has outstanding anti-oxidation ability, but also has radiation protection, skin repair, etc. Efficacy, can be applied to sunscreen, hand cream, toner, body milk and other cosmetics.
附图说明Description of drawings
图1为索罗金小球藻BZ942的培养液及其在显微镜下的观察;注:a代表培养的小球藻BZ942藻液,b代表显微镜物镜40x下小球藻BZ942的形态。Figure 1 shows the culture solution of Chlorella sorokinus BZ942 and its observation under a microscope; Note: a represents the cultured Chlorella BZ942 liquid, and b represents the morphology of Chlorella BZ942 under the microscope objective lens 40x.
图2为采用PCR方法扩增索罗金小球藻BZ942的ITS基因,鉴定其种属。Fig. 2 shows the PCR method to amplify the ITS gene of Chlorella sorokinus BZ942 and identify its species.
图3为采用PCR方法扩增索罗金小球藻BZ942的18s rRNA基因,鉴定其种属。Fig. 3 is the PCR method to amplify the 18s rRNA gene of Chlorella sorokinus BZ942, and identify its species.
图4为采用PCR方法扩增索罗金小球藻BZ942的COI基因,鉴定其种属。Fig. 4 is a PCR method to amplify the COI gene of Chlorella sorokinus BZ942 and identify its species.
图5为索罗金小球藻BZ942藻株的进化树图。Fig. 5 is a phylogenetic tree diagram of Chlorella sorokines BZ942 strain.
图6为应用索罗金小球藻BZ942水提液制备的小球藻面膜精华液;注:a代表应用小球藻BZ942制备的活性物质,b代表小球藻面膜精华液。Figure 6 shows the chlorella facial mask essence prepared by using the water extract of Chlorella sorogenus BZ942; Note: a represents the active substance prepared by using chlorella BZ942, and b represents the chlorella facial mask essence.
图7为应用索罗金小球藻BZ942制备面膜精华液的流程图。Fig. 7 is a flow chart of preparing facial mask essence by using Chlorella sorokinus BZ942.
具体实施方式Detailed ways
以下结合具体实施例来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但这些实施例仅是范例性的,并不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明的细节和形式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。The present invention will be further described below in conjunction with specific embodiments, and the advantages and characteristics of the present invention will become clearer along with the description. However, these embodiments are only exemplary and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the present invention can be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the protection scope of the present invention.
预备实施例1用于小球藻种属的分子鉴定的引物设计Preliminary Example 1 Primer Design for Molecular Identification of Chlorella Species
根据小球藻的ITS、18s rRNA、线粒体COI基因设计上下游引物,用于小球藻种属的分子鉴定。基因扩增引物序列如下:The upstream and downstream primers were designed according to the ITS, 18s rRNA, and mitochondrial COI genes of Chlorella for molecular identification of Chlorella species. The sequences of gene amplification primers are as follows:
ITS-F:5’-GGCAATAACAGGTCTGT-3’ITS-F: 5'-GGCAATAACAGGTCTGT-3'
ITS-R:5’-CCTCACGGTACTTGTTC-3’ITS-R:5'-CCTCACGGTACTTGTTC-3'
18s rRNA-F:5’-ATTGGAGGGCAAGTCTGGTG-3’18s rRNA-F: 5'-ATTGGAGGGCAAGTCTGGTG-3'
18s rRNA-R:5’-TGATCCTTCTGCAGGTTCACCTACG-3’18s rRNA-R: 5'-TGATCCTTCTGCAGGTTCACCTACG-3'
COI-F:5’-ATGTTGACTCGTTGGTTTTATT-3’COI-F: 5'-ATGTTGACTCGTTGGTTTTTATT-3'
COI-R:5’-CAGAATAAGTGTTGGTAAAGAAT-3’。COI-R: 5'-CAGAATAAGTGTTGGTAAAGAAT-3'.
实施例1索罗金小球藻BZ942分离纯化、筛选和鉴定Example 1 Separation, purification, screening and identification of Chlorella sorokinus BZ942
选取从四川省巴中市南江县(106.86°E,32.14°N)野外收集的稻田水样,用无菌水,对水样稀释1000倍,取200ul稀释后的液体,均匀涂布于含有50mg/L卡那霉素、100mg/L头孢霉素的BG11固体培养基上,于光照培养箱中倒置培养(28℃,12h光照/12h黑暗),培养约5d后,观察平板上是否出现绿色的单克隆藻株;待出现绿色的单克隆藻株后,利用无菌的枪头,挑出单克隆,在含有50mg/L卡那霉素、100mg/L头孢霉素抗生素的BG11培养基上划线,再置于光照培养箱中继续培养约5d,观察是否出现单克隆藻株,且培养基上无杂菌,如仍存在杂菌,按照上述方法继续划线,纯化藻株;平板上出现单克隆藻株,且无杂菌时,挑选单克隆藻株于含有50mg/L卡那霉素、100mg/L头孢霉素的BG11液体培养基中,于光照振荡培养箱中振荡培养(28℃,12h光照/12h黑暗,200rpm/min),获得藻液,将其命名为BZ942。Select paddy field water samples collected from Nanjiang County, Bazhong City, Sichuan Province (106.86°E, 32.14°N) in the field, dilute the water samples 1000 times with sterile water, take 200ul diluted liquid, and evenly spread on 50mg /L kanamycin, 100mg/L cephalosporin on BG11 solid medium, cultured upside down in a light incubator (28°C, 12h light/12h dark), after culturing for about 5 days, observe whether green spots appear on the plate Monoclonal algae strains; after green monoclonal algae strains appear, use a sterile pipette tip to pick out a single clone, and mark on the BG11 medium containing 50mg/L kanamycin and 100mg/L cephalosporin antibiotics Then put it in the light incubator and continue to cultivate for about 5 days to observe whether there are monoclonal algae strains, and there are no bacteria on the medium. If there are still bacteria, continue to draw lines according to the above method to purify the algae strains; When the monoclonal algae strains are free of miscellaneous bacteria, select the monoclonal algae strains and place them in BG11 liquid medium containing 50mg/L kanamycin and 100mg/L cephalosporin, and shake them in a light shaking incubator (28°C , 12h light/12h dark, 200rpm/min), the algae liquid was obtained, which was named BZ942.
取藻液BZ942于光学显微镜下观察,在物镜40x放大倍数下,观察发现藻株形态呈绿色、球形、单细胞,含有1个蛋白核,细胞直径约5微米,形态类似小球藻(图1)。取藻液BZ942(OD680>0.5)0.5mL于2mL离心管,经离心机10000rpm/min离心1min后,弃掉培养液,加入研磨钢珠,在组织研磨机上以40HZ振动频率,研磨6min,再加入无菌水50μL,10000rpm/min离心1min,取上清液1μL为模板。分别利用小球藻ITS-F+ITS-R、18srRNA-F+18s rRNA-R、COI-F+COI-R为引物,进行PCR扩增。取PCR产物10μL电泳后凝胶成像观察;剩余的PCR产物送样测序,测序引物为对应的ITS-F、18s rRNA-F或者COI-F。通过反向互补在线工具(http://www.detaibio.com/sms2/rev_comp.htmL)处理测序结果,得到反向互补序列,并将该序列通过NCBI在线工具BLAST(https://blast.ncbi.nlm.nih.gov/Blast.cgi)进行序列比对,寻找同源基因,从而分析其种属关系。Take the algae liquid BZ942 and observe it under the optical microscope. Under the 40x magnification of the objective lens, it is observed that the shape of the algae strain is green, spherical, single-celled, contains 1 protein nucleus, and the cell diameter is about 5 microns. The shape is similar to Chlorella (Fig. 1 ). Take 0.5 mL of algae liquid BZ942 (OD680>0.5) in a 2 mL centrifuge tube, centrifuge at 10,000 rpm/min for 1 min, discard the culture liquid, add grinding steel balls, and grind for 6 min on a tissue grinder at a vibration frequency of 40 Hz, then add no 50 μL of bacterial water was centrifuged at 10,000 rpm/min for 1 min, and 1 μL of the supernatant was taken as a template. Chlorella ITS-F+ITS-R, 18srRNA-F+18s rRNA-R, COI-F+COI-R were used as primers for PCR amplification. Take 10 μL of the PCR product and observe it by gel imaging after electrophoresis; the remaining PCR product is sent for sequencing, and the sequencing primer is the corresponding ITS-F, 18s rRNA-F or COI-F. The sequencing results were processed through the reverse complement online tool (http://www.detaibio.com/sms2/rev_comp.htmL), and the reverse complement sequence was obtained, and the sequence was passed through the NCBI online tool BLAST (https://blast.ncbi .nlm.nih.gov/Blast.cgi) for sequence alignment to find homologous genes and analyze their species relationship.
采用PCR扩增微藻ITS基因(SEQ ID No.1),测序后经过Blastn比对,发现BZ942与索罗金小球藻ITS基因亲缘关系相近,一致性达到90.4%(图2)。PCR was used to amplify the ITS gene of microalgae (SEQ ID No.1), and after sequencing, Blastn comparison revealed that BZ942 was similar to the ITS gene of Chlorella sorokini, with a consistency of 90.4% (Figure 2).
采用PCR扩增微藻18s rRNA基因(SEQ ID No.2),测序后经过Blastn比对,发现BZ942与索罗金小球藻核糖体RNA基因亲缘关系相近,一致性达到97.9%(图3)。PCR was used to amplify the microalgae 18s rRNA gene (SEQ ID No.2), and after sequencing, Blastn comparison revealed that BZ942 had a close relationship with the ribosomal RNA gene of Chlorella sorokini, with a consistency of 97.9% (Figure 3).
采用PCR扩增微藻COI基因(SEQ ID No.3),测序后经过Blastn比对,发现BZ942与索罗金小球藻线粒体COI基因亲缘关系相近,一致性达到98.67%(图4)。基于COI基因,进行进化树图分析,发现BZ942聚于索罗金小球藻分支(图5)PCR was used to amplify the microalgae COI gene (SEQ ID No.3), and after sequencing, Blastn comparison revealed that BZ942 was closely related to the mitochondrial COI gene of Chlorella sorokinus, with a consistency of 98.67% (Figure 4). Based on the COI gene, the phylogenetic tree analysis was carried out, and it was found that BZ942 was gathered in the Sorokin Chlorella branch (Figure 5)
综上,本实施例结合显微镜观察、基因测序以及序列分析鉴定出一株索罗金小球藻藻种(Chlorella sorokiniana),命名为小球藻BZ942,保藏于中国典型培养物保藏中心,保藏号为CCTCC M 20221450。To sum up, in this example, a Chlorella sorokiniana strain (Chlorella sorokiniana) was identified in combination with microscope observation, gene sequencing and sequence analysis, named Chlorella sorokiniana BZ942, and was preserved in the China Center for Type Culture Collection with the preservation number CCTCC M 20221450.
实施例2索罗金小球藻活性成分的提取The extraction of embodiment 2 Chlorella sorokinus active ingredient
应用实施例1鉴定的小球藻BZ942,通过BG11培养基无菌发酵培养3d,获得藻液,经离心机离心(13000rpm/min x 10min)、喷雾干燥机干燥(120℃),获得小球藻BZ942的藻粉。以藻粉为原料,以水为溶剂,称量藻粉5g、水200mL,混合均匀后,先经细胞超声破碎仪50%功率超声破碎10min,再经95℃水浴加热30min,将藻液经离心机10000rpm/min x 10min离心,收集上清液,最后经0.22μm滤膜过滤除菌,获得小球藻BZ942水提液。Apply the chlorella BZ942 identified in Example 1, through BG11 medium for aseptic fermentation and culture for 3 days, to obtain the algae liquid, centrifuge in a centrifuge (13000rpm/min x 10min), and dry (120°C) with a spray dryer to obtain chlorella Algae powder of BZ942. Using algae powder as raw material and water as solvent, weigh 5g of algae powder and 200mL of water. After mixing evenly, it is ultrasonically crushed by a cell ultrasonic breaker at 50% power for 10 minutes, then heated in a water bath at 95°C for 30 minutes, and the algae liquid is centrifuged. Centrifuge at 10000rpm/min x 10min, collect the supernatant, and finally filter and sterilize through a 0.22μm filter membrane to obtain the water extract of Chlorella BZ942.
实施例3应用索罗金小球藻活性成分制备小球藻面膜精华液Example 3 Preparation of Chlorella Facial Mask Essence by Using Sorokin Chlorella Active Components
应用实施例2制备的小球藻BZ942水提液,按照以下步骤制备1000g小球藻面膜精华液。Using the chlorella BZ942 water extract prepared in Example 2, prepare 1000g of chlorella mask essence according to the following steps.
第一步,在洁净车间,称取以下至烧杯:黄原胶0.5g、卡波姆2g、海藻酸钠3g、水797g,85℃~90℃加热并搅拌均匀至无白色固体;Step 1: In the clean workshop, weigh the following into a beaker: 0.5g xanthan gum, 2g carbomer, 3g sodium alginate, 797g water, heat at 85°C to 90°C and stir evenly until no white solid appears;
第二步,向上述烧杯中加入:甘油50g、丙二醇20g、三乙醇胺0.5g,搅拌均匀,停止加热,冷却至45℃以下;Step 2: Add 50g of glycerin, 20g of propylene glycol, and 0.5g of triethanolamine to the above beaker, stir evenly, stop heating, and cool to below 45°C;
第三步,加入小球藻水提液30g、山梨酸钾5g、角鲨烷30g、维生素C 2g、烟酰胺5g、熊果苷5g、玫瑰纯露50g,搅拌均匀,经乳化机乳化,获得面膜液初制品,静置2-3d;In the third step, add 30g of chlorella water extract, 5g of potassium sorbate, 30g of squalane, 2g of vitamin C, 5g of nicotinamide, 5g of arbutin, and 50g of rose hydrosol, stir evenly, and emulsify through an emulsifier to obtain The first product of mask liquid, let it stand for 2-3 days;
第四步,将面膜液初制品经辐射灭菌后,罐装,形成小球藻面膜精华液成品,配合面膜纸使用。The fourth step is to sterilize the primary product of the facial mask solution by radiation, and then pack it into a can to form a finished product of chlorella facial mask essence, which is used together with facial mask paper.
所制备的小球藻活性水提液及小球藻面膜精华液如图6所示。The prepared chlorella active water extract and chlorella mask essence are shown in Figure 6.
试验例1索罗金小球藻活性成分制备的小球藻面膜精华液的抗氧化能力评价试验Test example 1 Antioxidant ability evaluation test of the chlorella mask essence prepared by Sorokin chlorella active ingredient
取实施例3制备的面膜精华液1mL,用无菌水稀释100倍,以维生素C为阳性对照,利用DPPH自由基清除能力检测试剂盒,测定小球藻面膜精华液的抗氧化能力。Get the facial mask essence 1mL prepared in Example 3, dilute 100 times with sterile water, take vitamin C as positive control, utilize DPPH free radical scavenging ability detection kit, measure the antioxidant capacity of chlorella facial mask essence.
基于QB/T 2872-2017面膜标准,对面膜的感官、理化指标进行测定;随机取30人使用该面膜精华液,每晚使用1次,连续1周,进行使用测评。Based on the QB/T 2872-2017 facial mask standard, the sensory and physical and chemical indicators of the facial mask were measured; 30 people were randomly selected to use the facial mask essence once a night for 1 consecutive week for evaluation.
索罗金小球藻BZ942的抗氧化评价结果如表1、表2所示。The antioxidant evaluation results of Sorokin Chlorella BZ942 are shown in Table 1 and Table 2.
表1不同样品的DPPH清除率DPPH clearance rate of different samples in table 1
表2索罗金小球藻面膜精华液的感官及理化评价Table 2 Sensory and Physicochemical Evaluation of Sorokin Chlorella Mask Essence
由表1、图6a可以看出,索罗金小球藻BZ942的水提液为淡绿色清液(图6a),其具有较好的DPPH自由基清除能力,其中5mg/mL的索罗金小球藻BZ942水提液的DPPH清除率为70%,抗氧化效果佳。As can be seen from Table 1 and Figure 6a, the water extract of Chlorella sorokini BZ942 is a light green clear liquid (Figure 6a), which has a good DPPH free radical scavenging ability, wherein 5mg/mL of Chlorella sorokini BZ942 The DPPH clearance rate of the water extract is 70%, and the antioxidant effect is good.
由表1、表2、图6可以看出,应用索罗金小球藻BZ942,制备小球藻精华面膜液,该面膜液为半透明胶质状,具有天然的玫瑰清香,性质稳定,具有较好的耐热、耐寒性,经第三方使用后测评,主观反映该面膜精华液品质优异(表2、图6b);对该面膜精华液进行抗氧化能力评价,发现经过100倍稀释,仍具有显著的抗氧化能力,DPPH清除率超过了90%(表1)。As can be seen from Table 1, Table 2, and Figure 6, Chlorella sorogenus BZ942 is used to prepare the chlorella essence mask liquid, which is translucent colloidal, has a natural rose fragrance, is stable in properties, and has good The heat resistance and cold resistance of the mask essence were evaluated by a third party after use, and subjectively reflected that the mask essence was of excellent quality (Table 2, Figure 6b); the antioxidant capacity of the mask essence was evaluated, and it was found that after 100-fold dilution, it still had significant Antioxidant capacity, DPPH scavenging rate exceeded 90% (Table 1).
综上,应用索罗金小球藻BZ942制备的面膜精华液综合性能优良,抗氧化效果好,具有良好的美容护肤效果。In conclusion, the facial mask essence prepared by Chlorella sorokinensis BZ942 has excellent comprehensive performance, good anti-oxidation effect, and good skin care effect.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211367265.6A CN116059138A (en) | 2022-11-02 | 2022-11-02 | Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211367265.6A CN116059138A (en) | 2022-11-02 | 2022-11-02 | Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116059138A true CN116059138A (en) | 2023-05-05 |
Family
ID=86179339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211367265.6A Pending CN116059138A (en) | 2022-11-02 | 2022-11-02 | Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116059138A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116650392A (en) * | 2023-06-14 | 2023-08-29 | 广州科丽德日化科技有限公司 | A composition with anti-aging and/or wrinkle-improving effects and its application in the preparation of skin care products |
| CN117089460A (en) * | 2023-08-23 | 2023-11-21 | 中国农业科学院都市农业研究所 | Soxhlet Luo Jinxiao chlorella DP-5 for bioconversion of nano-selenium, application thereof and nano-selenium preparation method |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444542A (en) * | 2007-10-25 | 2009-06-03 | 国际绿藻有限公司 | Cryptomonadales Extract |
| EP2157167A1 (en) * | 2008-08-13 | 2010-02-24 | Cognis IP Management GmbH | Process for obtaining Lutein from green algae |
| US20110250178A1 (en) * | 2008-11-07 | 2011-10-13 | Solazyme ,Inc. | Cosmetic compositions comprising microalgal components |
| CN103952313A (en) * | 2013-12-31 | 2014-07-30 | 上海交通大学 | Imnetic algae strain Chlorella sorokiniana HN01 and application thereof |
| BR102014033159A2 (en) * | 2014-12-18 | 2016-11-22 | Univ Fed Do Rio Grande | nutricosmetic formulations for minimizing the effects of the human aging process using biomass and / or microalgae (s) and / or cyanobacterial extract (s) in isolation and / or in combination with other compound (s) |
| FR3064481A1 (en) * | 2017-03-30 | 2018-10-05 | Societe Industrielle Limousine D'application Biologique | USE OF A CHLORELLA SOROKINIANA EXTRACT IN COSMETICS AND PARTICULAR EXTRACTS OF CHLORELLA SOROKINIANA |
| DE202018105422U1 (en) * | 2018-06-21 | 2018-10-19 | U.S. Nutraceuticals, Llc D/B/A Valensa International | A composition for relieving joint pain using hyaluronic acid and egg shell membrane components |
| CN110604234A (en) * | 2019-05-22 | 2019-12-24 | 中国科学院水生生物研究所 | Application of Chlorella sorokini in functional feed for improving fish health |
| CN113924132A (en) * | 2019-05-07 | 2022-01-11 | 罗盖特公司 | Novel polysaccharide-based hydrogel scaffold for wound care |
| US20220010264A1 (en) * | 2018-11-21 | 2022-01-13 | Algenuity Holdings Ltd | Modified strains of chlorella vulgaris and method of production |
| RU2774294C1 (en) * | 2021-08-18 | 2022-06-16 | Общество с ограниченной ответственностью «Альготек Грин Технолоджи» | Plankton eurybiontic strain of microalgae chlorella sorokiniana agt intended to improve the ecological state of water bodies |
| CN114805485A (en) * | 2022-05-26 | 2022-07-29 | 青岛麦迪赛斯医疗技术有限公司 | Chlorella bioactive peptide and application thereof in preparation of anti-aging essence |
-
2022
- 2022-11-02 CN CN202211367265.6A patent/CN116059138A/en active Pending
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444542A (en) * | 2007-10-25 | 2009-06-03 | 国际绿藻有限公司 | Cryptomonadales Extract |
| EP2157167A1 (en) * | 2008-08-13 | 2010-02-24 | Cognis IP Management GmbH | Process for obtaining Lutein from green algae |
| US20110250178A1 (en) * | 2008-11-07 | 2011-10-13 | Solazyme ,Inc. | Cosmetic compositions comprising microalgal components |
| CN103952313A (en) * | 2013-12-31 | 2014-07-30 | 上海交通大学 | Imnetic algae strain Chlorella sorokiniana HN01 and application thereof |
| BR102014033159A2 (en) * | 2014-12-18 | 2016-11-22 | Univ Fed Do Rio Grande | nutricosmetic formulations for minimizing the effects of the human aging process using biomass and / or microalgae (s) and / or cyanobacterial extract (s) in isolation and / or in combination with other compound (s) |
| FR3064481A1 (en) * | 2017-03-30 | 2018-10-05 | Societe Industrielle Limousine D'application Biologique | USE OF A CHLORELLA SOROKINIANA EXTRACT IN COSMETICS AND PARTICULAR EXTRACTS OF CHLORELLA SOROKINIANA |
| DE202018105422U1 (en) * | 2018-06-21 | 2018-10-19 | U.S. Nutraceuticals, Llc D/B/A Valensa International | A composition for relieving joint pain using hyaluronic acid and egg shell membrane components |
| US20220010264A1 (en) * | 2018-11-21 | 2022-01-13 | Algenuity Holdings Ltd | Modified strains of chlorella vulgaris and method of production |
| CN113924132A (en) * | 2019-05-07 | 2022-01-11 | 罗盖特公司 | Novel polysaccharide-based hydrogel scaffold for wound care |
| CN110604234A (en) * | 2019-05-22 | 2019-12-24 | 中国科学院水生生物研究所 | Application of Chlorella sorokini in functional feed for improving fish health |
| RU2774294C1 (en) * | 2021-08-18 | 2022-06-16 | Общество с ограниченной ответственностью «Альготек Грин Технолоджи» | Plankton eurybiontic strain of microalgae chlorella sorokiniana agt intended to improve the ecological state of water bodies |
| CN114805485A (en) * | 2022-05-26 | 2022-07-29 | 青岛麦迪赛斯医疗技术有限公司 | Chlorella bioactive peptide and application thereof in preparation of anti-aging essence |
Non-Patent Citations (3)
| Title |
|---|
| SONGSERM, RATTANAPOR: ""GC-MS profiling, anti-oxidant and anti-diabetic assessments of extracts from microalgae Scenedesmus falcatus (KU.B1) and Chlorella sorokiniana (KU.B2)"", PLANT SCIENCE TODAY, vol. 9, no. 3, 3 August 2022 (2022-08-03), pages 632 - 641 * |
| 吴思伟: ""一株产胞外多糖微藻的分离鉴定及其多糖抗氧化活性的研究"", 食品与发酵工业, vol. 47, no. 27, 13 May 2021 (2021-05-13), pages 193 - 200 * |
| 张玲: ""小球藻(Chlorella sorokiniana C74)的培养及活性物质的研究"", 中国优秀硕士学位论文全文数据库基础科学辑, no. 1, 15 January 2016 (2016-01-15), pages 006 - 303 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116650392A (en) * | 2023-06-14 | 2023-08-29 | 广州科丽德日化科技有限公司 | A composition with anti-aging and/or wrinkle-improving effects and its application in the preparation of skin care products |
| CN117089460A (en) * | 2023-08-23 | 2023-11-21 | 中国农业科学院都市农业研究所 | Soxhlet Luo Jinxiao chlorella DP-5 for bioconversion of nano-selenium, application thereof and nano-selenium preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111088174B (en) | Saccharomycetes Fungiensis with oxidation resistance and whitening effect and application thereof | |
| CN116059138A (en) | Soxhlet Luo Jinxiao Chlorella with antioxidant activity and its application in cosmetics | |
| WO2022199660A1 (en) | Lactobacillus rhamnosus, ferment lysate for regulating skin microecology, preparation method, and application | |
| CN102816716A (en) | Extraction and application of exopolysaccharide metabolite of bacillus amyloliquefaciens strain | |
| CN114752504B (en) | Schizophyllum commune strain YSC1, intracellular extracellular polysaccharide prepared based on Schizophyllum commune, cosmetic and preparation method thereof | |
| CN112708652A (en) | Avocado oil-in-water liquid state fermentation product and preparation method and application thereof | |
| CN114703108A (en) | Lactobacillus mucilaginosus strain and application thereof in improvement of facial redness and type I rosacea | |
| CN116999374A (en) | Bifidobacterium adolescentis milk fermentation product, products containing the same and preparation and application thereof | |
| CN116855559A (en) | Preparation method and application of Chlamydomonas nivalis oligosaccharide for regulating skin microecology | |
| CN114703066A (en) | Scenedesmus as well as extraction method and application of active ingredients of Scenedesmus | |
| CN112190513B (en) | A kind of pomegranate peel, schisandra fermented stock solution and its preparation method and application | |
| CN108066237B (en) | Composition with whitening and spot-fading effects, application thereof and skin care product | |
| CN114891699A (en) | Lactobacillus salivarius regulating flora balance | |
| CN119547898A (en) | A live bacterial preparation of Lactobacillus paracasei strain and its preparation method and application | |
| CN109810918B (en) | Bacillus atrophaeus with effect of preventing wolfberry leaf blight, biological agent and application of biological agent | |
| CN116218694B (en) | Saccharomyces cerevisiae, galactose yeast-like fermentation product filtrate with effects of tightening and tendering skin, brightening and repairing | |
| CN114404344B (en) | Yeast/barley seed fermentation product, product containing same and preparation method and application thereof | |
| CN110755319A (en) | Hemp flower and leaf fermentation method, hemp flower and leaf fermentation extract and cosmetics | |
| CN113967188B (en) | Preparation method and application of bamboo leaf fermentation filtrate | |
| CN117731574A (en) | Camellia seed fermented facial cleanser and preparation method thereof | |
| CN115369047A (en) | Kluyveromyces marxianus strain and application thereof | |
| JP6604590B2 (en) | Euglena and culture method thereof, paramylon and production method thereof | |
| CN116602907A (en) | Fermented broth with emulsifying properties, products containing same, preparation method and application thereof | |
| CN114796086B (en) | Multifunctional pet care agent and preparation method thereof | |
| CN117551589B (en) | Use of lysate of bifidobacterium longum subspecies infantis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |